The Kyowa Hakko Kirin Group has established “Transparency Policy for the Relationships between Corporate Activities, Healthcare Professionals, Healthcare Organizations and Patient Organizations” and strive to ensure our relationships among them in an ethical and transparent manner.
Enacted: 26th May, 2017
We at the Kyowa Hakko Kirin Group (hereafter referred to as “KHK” and/or “Our Group”) strive to become a corporate group that is trusted by society through behavior based on high ethical standards and thereby fulfill our management philosophy, “Our Group strives to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.” Toward this end, we have enacted “Kyowa Hakko Kirin Group Compliance Policy” with which all directors and employees of Our Group must comply, and have published it on our website.
Our Group collaborates with medical personnel and institutions (hereafter referred to collectively as “the Medical Community”) in pursuit of innovative drug discovery, regulatory activities and the subsequent launch of new products. In recent years, the scope of our business activities has expanded to patient organizations as we seek to facilitate patient-participatory medical care. We believe that these relationships are an indispensable contribution to public health and wellbeing.
In the process of such collaborations, conflicts of interest may arise among Our Group, the Medical Community and patient organizations. Therefore, Our Group should recognize and consider the independence of the Medical Community and patient organizations to avoid such conflicts.
Our Group is committed to acting in an ethical and transparent manner, including in relation to the public disclosure of information on the provision of funding to the Medical Community and patient organizations (hereafter referred to as “Transparency”).
Based on the above background, Our Group will ensure Transparency in our relationships with the Medical Community and patient organizations in line with the following policy:
© 2007 Kirin Holdings Company, Limited.